Title:
IMMUNE-ONCOLYTIC VIRUS COMBINATION DRUG FOR ENHANCING SYSTEMIC IMMUNE RESPONSE AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/143221
Kind Code:
A1
Abstract:
Disclosed in the present invention is an immune-oncolytic virus combination drug for enhancing systemic immune response, comprising oncolytic viruses carrying foreign gene fragments derived from humans or animals. According to the present invention, tumor antigens are exposed by the lysis of oncolytic viruses, and immunity is mediated by simultaneously expressed T cell coactivators for the treatment of tumors.
Inventors:
YU LI (CN)
Application Number:
PCT/CN2019/098798
Publication Date:
July 16, 2020
Filing Date:
August 01, 2019
Export Citation:
Assignee:
SICHUAN ANKEKANG BIOMEDICINE CO LTD (CN)
International Classes:
A61K38/19
Domestic Patent References:
| WO2017197207A1 | 2017-11-16 |
Foreign References:
| US20040131590A1 | 2004-07-08 | |||
| CA3006859A1 | 2017-06-22 | |||
| CN107406859A | 2017-11-28 |
Attorney, Agent or Firm:
CHENGDU TIANMING PATENT AGENCY (SPECIAL GENERAL PARTNERSHIP) (CN)
Download PDF:
Previous Patent: IMMUNOCHROMATOGRAPHIC ASSAY DEVICE
Next Patent: FABRICATED SUSPENDED CEILING STRUCTURE AND INSTALLATION METHOD THEREFOR
Next Patent: FABRICATED SUSPENDED CEILING STRUCTURE AND INSTALLATION METHOD THEREFOR